(Q39421753)

11 September 2017

1 reference

title

The place of radiation therapy in the treatment of non-Hodgkin's lymphomas (English)

2 references

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

11 September 2017

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

adaptive radiation therapy

12 April 2022

main subject

0 references

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

author name string

Hellman S

1

1 reference

11 September 2017

Chaffey JT

2

1 reference

11 September 2017

Rosenthal DS

3

1 reference

11 September 2017

Moloney WC

4

1 reference

11 September 2017

Canellos GP

5

1 reference

11 September 2017

Skarin AT

6

1 reference

11 September 2017

S. Hellman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

J. T. Chaffey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

D. S. Rosenthal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

W. C. Moloney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

G. P. Canellos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

A. T. Skarin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A65208

12 April 2022

language of work or name

English

0 references

publication date

1 February 1977

1 reference

full work available at URL

11 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

1 reference

11 September 2017

volume

39

1 reference

11 September 2017

issue

2 Suppl

1 reference

11 September 2017

page(s)

843-851

1 reference

Primary Lymphoma of the Gastrointestinal Tract

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%2B%3C843%3A%3AAID-CNCR2820390720%3E3.0.CO%3B2-F

Reticulum-cell sarcoma. 3. Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%2B%3C843%3A%3AAID-CNCR2820390720%3E3.0.CO%3B2-F

Reticulum-Cell Sarcoma Treated by Radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%2B%3C843%3A%3AAID-CNCR2820390720%3E3.0.CO%3B2-F

Primary Malignant Lymphoma of the Oral Cavity and Paranasal Sinuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197702%2939%3A2%2B%3C843%3A%3AAID-CNCR2820390720%3E3.0.CO%3B2-F

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

21 January 2018

1

76

227

Bagley

1972

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy

12 April 2022

3

35

1050

Berd

1975

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

4

23

613

Bohannon

1963

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

8

28

811

Carbone

1968

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Advanced diffuse histiocytic lymphoma, a potentially curable disease

12 April 2022

12

248

DeVita

1975

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Letter: Classification of non-Hodgkin's lymphomas.

12 April 2022

13

1295

Dorfman

1974

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

CHLORAMBUCIL THERAPY FOR LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA

12 April 2022

14

191

444

Ezdinli

1965

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia

12 April 2022

15

23

900

Ezdinli

1969

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas

12 April 2022

18

32

672

Goffinet

1973

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

12 April 2022

20

33

0 references

The treatment of non-Hodgkin's lymphoma

21

36

804

Hellman

1975

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Efficacy of cyclophosphamide in the management of reticulum cell sarcoma

12 April 2022

24

19

1386

Hyman

1966

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Primary management of advanced lymphosarcoma with radiotherapy

12 April 2022

25

25

787

Johnson

1970

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Non-Hodgkin's lymphomas.V. Results of radiotherapy

12 April 2022

27

32

682

Jones

1973

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Non-Hodgkin's lymphomas.I. Bone marrow involvement

12 April 2022

28

29

954

Jones

1972

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Prognosis of stage I lymphosarcoma and reticulum-cell sarcoma.

12 April 2022

31

284

230

Lipton

1971

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma

12 April 2022

32

25

1018

Lowenbraun

1970

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

12 April 2022

33

28

306

Luce

1971

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

The clinical course of Hodgkin's disease and other malignant lymphomas treated with radical radiation therapy

12 April 2022

41

105

618

Prosnitz

1969

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases

12 April 2022

42

9

792

Rappaport

1956

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response

12 April 2022

47

34

1023

Skarin

1974

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma.

12 April 2022

49

195

173

Stutzman

1966

1 reference

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2+%3C843::AID-CNCR2820390720%3E3.0.CO;2-F

Stage I and II non-Hodgkin's lymphoma. Results of regional radiation therapy

12 April 2022

51

117

56

Vijungco

1973

0 references

Identifiers

10.1002/1097-0142(197702)39:2+<843::AID-CNCR2820390720>3.0.CO;2-F

1 reference

11 September 2017

1 reference